The recombinant hepatitis 6 virus antigen was obtained as a chimaeric protein fused to the Cterminus of the phage MS2 RNA polymerase. Following induction of the temperature-sensitive promoter, two major polypeptides of about 34 kDa and 29 kDa, and two minor peptides about 21 kDa and 18 kDa, were obtained on PAGE. The 34-kDa protein was identified as the expected recombinant protein by confirming 82% of the primary structure using fast-atom-bombardment mass spectrometry. The most represented degradation product, i. e. the 29-kDa polypeptide, was also characterized by means of mass spectrometry and found to be produced by cleavage between amino acids 261 and 265. The presence of two main protein bands, with a similar difference in size, is also a typical feature of 6 antigens, both extracted and recombinant, and it is considered to be derived either from heterogeneity of viral sequences, which can encode hepatitis 6 antigen proteins of 195 and 214 amino acids, or from proteolysis of a single precursor. Since the data were obtained with a single viral sequence coding for 195 amino acids fused to 106 residues from MS2 polymerase, there is direct evidence that intrinsic structural properties of the protein sequence are able to cause a specific proteolysis resulting in the presence of two major forms, of which the smaller is 35 -40 amino acids at the C-terminus. The recombinant protein can be used as an antigenic substitute of viral antigens both for immunoassays and for the preparation of anti-(hepatitis 6 virus) antisera.Hepatitis 6 virus (HDV) is a defective single-stranded RNA virus which can only infect patients with acute or chronic infection by hepatitis B virus [l, 21. The hepatitis 6 antigen is essentially the only specific protein to be expressed as a consequence of HDV infection and which is immunogenic in infected patients [3]. It turned out that this protein is encoded by open reading frame (ORF) 5 in the viral genome and is specifically recognized by immune sera [4]. The diagnosis of hepatitis 6 virus infection is based both on the detection of the viral antigen and on the presence of the relative antibodies [l, 21. The availability of reproducible and safe preparations of the antigen is then necessary for the assembling of a clinical immunoassay for the detection of this viral disease. Viral preparations extracted from serum or liver tissue Now. The novel nucleotide sequence data published here have been submitted to the EMBL sequence data bank and are available under accession number X63373. The novel amino acid sequence data published here have been submitted to the EMBL sequence data bank. might be infective and yield a limited amount of material. To overcome these limitations, and to obtain from an unlimited and reproducible source a recombinant protein capable of substituting extractive antigens, the cloning and expression of the DNA sequence of hepatitis 6 antigen was undertaken.The recombinant protein was obtained together with several degradation products, similar to extracted hepatitis 6 antige...